These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30672775)

  • 1. Normal Expression of SRY-related HMG-BOX Gene 10 (SOX-10) in Recent and Old Cutaneous Scars is a Potential Mimicker of Desmoplastic Malignant Melanoma.
    Febres-Aldana CA; Alexis J
    Appl Immunohistochem Mol Morphol; 2020 Mar; 28(3):197-204. PubMed ID: 30672775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi.
    Kucher C; Zhang PJ; Pasha T; Elenitsas R; Wu H; Ming ME; Elder DE; Xu X
    Am J Dermatopathol; 2004 Dec; 26(6):452-7. PubMed ID: 15618925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX-10 staining in dermal scars.
    Behrens EL; Boothe W; D'Silva N; Walterscheid B; Watkins P; Tarbox M
    J Cutan Pathol; 2019 Aug; 46(8):579-585. PubMed ID: 30950082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NGFR (p75) expression in cutaneous scars; Further evidence for a potential pitfall in evaluation of reexcision scars of cutaneous neoplasms, in particular desmoplastic melanoma.
    Otaibi S; Jukic DM; Drogowski L; Bhawan J; Radfar A
    Am J Dermatopathol; 2011 Feb; 33(1):65-71. PubMed ID: 21178583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologic differentiation of desmoplastic melanoma from cicatrices.
    Kaneishi NK; Cockerell CJ
    Am J Dermatopathol; 1998 Apr; 20(2):128-34. PubMed ID: 9557779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar.
    Ramos-Herberth FI; Karamchandani J; Kim J; Dadras SS
    J Cutan Pathol; 2010 Sep; 37(9):944-52. PubMed ID: 20653825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX-10 expression in cutaneous myoepitheliomas and mixed tumors.
    Naujokas A; Charli-Joseph Y; Ruben BS; Yeh I; LeBoit PE; McCalmont TH; Pincus LB
    J Cutan Pathol; 2014 Apr; 41(4):353-63. PubMed ID: 24329979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100-positive spindle cells in scars: a diagnostic pitfall in the re-excision of desmoplastic melanoma.
    Chorny JA; Barr RJ
    Am J Dermatopathol; 2002 Aug; 24(4):309-12. PubMed ID: 12142609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmoplastic melanoma: an updated immunohistochemical analysis of 40 cases with a proposal for an additional panel of stains for diagnosis.
    Plaza JA; Bonneau P; Prieto V; Sangueza M; Mackinnon A; Suster D; Bacchi C; Estrozi B; Kazakov D; Kacerovska D; Falconieri G; Suster S
    J Cutan Pathol; 2016 Apr; 43(4):313-23. PubMed ID: 26661921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of nodal metastases in melanoma using sox-10.
    Jennings C; Kim J
    Am J Dermatopathol; 2011 Jul; 33(5):474-82. PubMed ID: 21552103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmoplastic and spindle-cell malignant melanoma. An immunohistochemical study.
    Longacre TA; Egbert BM; Rouse RV
    Am J Surg Pathol; 1996 Dec; 20(12):1489-500. PubMed ID: 8944042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100 expression in cutaneous scars: a potential diagnostic pitfall in the diagnosis of desmoplastic melanoma.
    Robson A; Allen P; Hollowood K
    Histopathology; 2001 Feb; 38(2):135-40. PubMed ID: 11207826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics.
    Koch MB; Shih IM; Weiss SW; Folpe AL
    Am J Surg Pathol; 2001 Jan; 25(1):58-64. PubMed ID: 11145252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical cells in human cutaneous re-excision scars for melanoma express p75NGFR, C56/N-CAM and GAP-43: evidence of early Schwann cell differentiation.
    Trejo O; Reed JA; Prieto VG
    J Cutan Pathol; 2002 Aug; 29(7):397-406. PubMed ID: 12139634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYB, CD117 and SOX-10 expression in cutaneous adnexal tumors.
    Evangelista MT; North JP
    J Cutan Pathol; 2017 May; 44(5):444-450. PubMed ID: 28098399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melan-A positive dermal cells in malignant melanoma in situ.
    Danga ME; Yaar R; Bhawan J
    J Cutan Pathol; 2015 Jun; 42(6):388-93. PubMed ID: 25726939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to 'Atypical cells in human cutaneous re-excision scars for melanoma express p75NGFR, C56/N-CAM and GAP-43: evidence of early Schwann cell differentiation'.
    Markowitch W
    J Cutan Pathol; 2003 Apr; 30(4):284. PubMed ID: 12680963
    [No Abstract]   [Full Text] [Related]  

  • 18. Can SOX-10 or KBA.62 Replace S100 Protein in Immunohistochemical Evaluation of Sentinel Lymph Nodes for Metastatic Melanoma?
    Vrotsos E; Alexis J
    Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):26-9. PubMed ID: 25611246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX10 expression in cutaneous scars: a potential diagnostic pitfall in the evaluation of melanoma re-excision specimens.
    Jackett LA; McCarthy SW; Scolyer RA
    Pathology; 2016 Oct; 48(6):626-8. PubMed ID: 27580960
    [No Abstract]   [Full Text] [Related]  

  • 20. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
    Gleason BC; Nascimento AF
    Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.